ALDER BIOPHARMACEUTICALS INC Consulting Agreements
4 Contracts & Agreements
- Transition and Consulting Agreement between Alder BioPharmaceuticals, Inc. and John A. Latham, Ph.D. dated March 28, 2019 (Filed With SEC on May 2, 2019)
- Amendment to Separation and Consulting Agreement with Randy Schatzman dated September 12, 2018 (Filed With SEC on November 5, 2018)
- Separation and Consulting Agreement between the Company and Randall C. Schatzman dated March 26, 2018 (Filed With SEC on May 8, 2018)
- Separation and Consulting Agreement between Alder BioPharmaceuticals, Inc. and Timothy M. Whitaker, M.D., dated June 3, 2016 (Filed With SEC on February 26, 2018)